Artificial intelligence | Pharmaceuticals | Regulatory Rapporteur

Skip to main content
Skip to navigation

Artificial intelligence articles

Sandbox of trust: Regulated AI for health promotion and disease prevention

2025-06-06T14:07:00+01:00By Catarina Carrão

This article explores the capacity and potential for AI tools in analysing health data and helping with disease prevention.

Prescribing efficiency: Using generative artificial intelligence for pharmacovigilance
2025-05-02T13:42:00+01:00By Ihab Mansoor and Matthew Rector
The role of artificial intelligence in regulatory affairs
2025-01-10T08:54:00+00:00By Rudy Fuentes, Sean Schofield and Lubomir Zahariev
MD2/IVD2: Unravelling AI as a medical device - Insights into the EU AI Act and other global perspectives
2024-11-08T06:56:00+00:00By Margareth Jorvid
Breaking barriers: the future of CMC powered by AI
2024-10-11T10:24:00+01:00By Mariam Amer, Eric Kelly, George Oliarnyk and Tiejun Wang
Unveiling the synergy of AI’s regulatory harmony in shaping the future of biopharmaceutical progress
2024-04-03T12:00:00+01:00By Baily Thomas, Madison Burns, Danielle Helton Corwin and Eddie Reilly
Developing a digital people strategy to harness the power of generative AI
2024-02-09T16:30:00+00:00By Sarah Chan, Danielle McVey and of the TOPRA RegOps SPIN group

Sink or swim: the changing tides of device regulation
2024-02-08T00:05:00+00:00By Esteban Herrero-Martinez and Dejan Brkic
Chemical characterisation: a critical first step for medical device development
2024-02-08T00:05:00+00:00By Jocivania Oliveira da Silva and Marielle Fournier
Overview of medical device regulations in Canada
2024-02-08T00:05:00+00:00By Hasnaa Fatehi
AI meets medtech:
big opportunities
require a
measured approach
2024-02-08T00:05:00+00:00By Jacques du Preez
EU MDR implementation – what is changing for the medical device industry?
2024-02-08T00:05:00+00:00By Ravi Mishra, Vivek Singh Bhagoor, Dharti Shah, Pinki Mishra, Harika Potta, Vesna Sevaljevic, Branislav Radivojevic, Deepti Jagga, Scott Krygier, Vivek Tomar and Allison Gillespie
The increasing complexity of biological medicinal products
2024-01-05T00:05:00+00:00By Julie Warner and and Ash Ramzan

More AI stories